Literature DB >> 12841394

The Mexican approach to conduct nonmyeloablative stem cell transplantation should not be overlooked.

Guillermo J Ruiz-Argüelles, David Gómez-Almaguer.   

Abstract

Mesh：

Year:  2003        PMID： 12841394     DOI： 10.1007/bf02986624

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  13 in total

1.  Oupatient programs of myeloablative chemotherapy, autologous and allogeneic bone marrow transplantation.

Authors:  G J Ruiz Arguelles
Journal:  Haematologica       Date:  2000-12       Impact factor: 9.941

2.  Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.

Authors:  G J Ruiz-Argüelles; D Gómez-Almaguer; A Ruiz-Argüelles; O González-Llano; O G Cantú; J C Jaime-Pérez
Journal:  Am J Hematol       Date:  2001-04       Impact factor: 10.047

Review 3.  Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT).

Authors:  L Vindeløv
Journal:  Eur J Haematol       Date:  2001-02       Impact factor: 2.997

4.  Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.

Authors:  S Giralt; E Estey; M Albitar; K van Besien; G Rondón; P Anderlini; S O'Brien; I Khouri; J Gajewski; R Mehra; D Claxton; B Andersson; M Beran; D Przepiorka; C Koller; S Kornblau; M Kørbling; M Keating; H Kantarjian; R Champlin
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

5.  Allogeneic stem cell transplantation using non-myeloablative conditioning regimens: results of the Mexican approach.

Authors:  Guillermo J Ruiz-Argüelles
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  Follow up of hemopoietic chimerism in individuals given allogeneic hemopoietic stem cell allografts using an immunosuppressive, non-myeloablative conditioning regimen: a prospective study in a single institution.

Authors:  Guillermo J Ruiz-Argüelles; Briceida López-Martíneza; Ma Rayo Santellán-Olea; Glexsy Abreu-Díaz; Virginia Reyes-Núñez; Alejandro Ruiz-Argüelles; Javier Garcés-Eisele
Journal:  Leuk Lymphoma       Date:  2002-07

7.  Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases.

Authors:  D Gómez-Almaguer; G J Ruiz-Argüelles; A Ruiz-Argüelles; O González-Llano; O E Cantú; N E Hernández
Journal:  Bone Marrow Transplant       Date:  2000-01       Impact factor: 5.483

8.  Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: a single institution experience.

Authors:  Guillermo J Ruiz-Argüelles; Briceida López-Martínez; David Gómez-Rangel; Erick Estrada; Antonio Marín-López; Gerardo Bravo-Hernández; Juan Manuel Hernández
Journal:  Hematology       Date:  2003-06       Impact factor: 2.269

9.  No cytomegalovirus-related deaths after non-ablative stem cell allografts.

Authors:  Guillermo J Ruiz-Argüelles; David Gómez-Almaguer; Briceida López-Martínez; Samuel Ponce-De-León; Olga G Cantú-Rodriguez; José C Jaime-Pérez
Journal:  Hematology       Date:  2002-04       Impact factor: 2.269

10.  Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience.

Authors:  David Gómez-Almaguer; Guillermo J Ruiz-Argüelles; Luz del Carmen Tarín-Arzaga; Oscar González-Llano; José Carlos Jaime-Pérez; Briceida López-Martínez; Olga G Cantú-Rodríguez; José Luis Herrera-Garza
Journal:  Biol Blood Marrow Transplant       Date:  2003-03       Impact factor: 5.742
View more
  1 in total

1.  Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico.

Authors:  José Carlos Jaime-Pérez; Alberto Carlos Heredia-Salazar; Olga G Cantú-Rodríguez; Homero Gutiérrez-Aguirre; César Daniel Villarreal-Villarreal; Consuelo Mancías-Guerra; José Luís Herrera-Garza; David Gómez-Almaguer
Journal:  Oncologist       Date:  2015-03-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.